Komori
Annual Securities Report4932ALMADO,INC.Chemicals

Annual Securities Report — FY2025

What ALMADO,INC. reported for the period from 2025-04-01 to 2026-03-31. Filed by ALMADO, INC.

How much it says
45Typical
What moved here
5named for the first time
Its own wording
52terms
Which filing this is
16/ 16newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist

Revenue from the eggshell membrane healthcare business increased, driven by customer acquisition and growth in subscription members, centered on direct-to-consumer e-commerce, as well as expansion of stores carrying the products through external general distribution. However, operating profit declined, and net income for the period also decreased, due to weak OEM sales and TV shopping, together with the proactive use of advertising expenses for direct sales.

Komori's summary of this document, not the document's own words.
45Typical
How much this filing saysA weighted roll-up of 10 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 35 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
64
Detailed
Magnitude of change
38
Thin
Strategic shift
60
Detailed
Capital movements
75
Very detailed
Disclosure Gaps
0
Almost nothing
Future commitments
68
Detailed
Change in Risk
23
Almost nothing
Financial and Capital Policy
13
Almost nothing
Product Portfolio
35
Thin
Technology Position
73
Detailed
Confidence in Strategic Bets
R&D spend93百万円Money spent making new things.
Cash left over7億円Cash from the business, less what went into equipment.
Spent on equipment34百万円Plants, machines — things meant to last.
Employees93Headcount at the end of this period.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.
ALMADO,INC. — FY2025 | Komori